European Medicines Agency approves a third dose of the Pfizer-BioNTech COVID-19 vaccine for people aged over 18-years-old.
The European Medicines Agency approves a third dose of the Pfizer-BioNTech COVID-19 vaccine for people aged over 18-years-old. However, it was up to member states to decide whether to use them.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthEuropean Medicines Agency approves a third dose of the Pfizer-BioNTech COVID-19 vaccine for people aged over 18-years-old.
View Premium plansBrowse free archive reportsThe European Medicines Agency approves a third dose of the Pfizer-BioNTech COVID-19 vaccine for people aged over 18-years-old. However, it was up to member states to decide whether to use them.